These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26000924)

  • 21. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
    Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between bone marrow stromal cell antigen 1 gene polymorphisms and the susceptibility to Parkinson's disease: a meta-analysis.
    Wang S; Xu YF; Ding XY; Liu ZR; Ding Y; Jin B; Wang S; Ding MP
    Neurosci Lett; 2015 Jul; 599():120-4. PubMed ID: 25986899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism in MIR4697 but not VPS13C, GCH1, or SIPA1L2 is associated with risk of Parkinson's disease in a Han Chinese population.
    Yang X; Zheng J; An R; Tian S; Zhao Q; Chen Y; Huang H; Ning PP; Song Y; Xu Y
    Neurosci Lett; 2017 May; 650():8-11. PubMed ID: 28380328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Wu YL; Ding XX; Sun YH; Yang HY; Sun L
    J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the RIC3 gene in Han Chinese patients with Parkinson's disease.
    He D; Hu P; Deng X; Song Z; Yuan L; Yuan X; Deng H
    Neurosci Lett; 2017 Jul; 653():351-354. PubMed ID: 28606768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.
    Zhao X; Wu Y; Zhao C; Feng M
    Neurol Sci; 2016 Jul; 37(7):1119-26. PubMed ID: 27023076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between four gene polymorphisms and their association with patients with Parkinson's disease in a Chinese Han population.
    Lv Z; Tian W; Ma Q; Hao Y; Yang Y
    Int J Neurosci; 2017 Dec; 127(12):1154-1160. PubMed ID: 28535700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
    De La Hera DP; Corradi GR; Adamo HP; De Tezanos Pinto F
    Biochem J; 2013 Feb; 450(1):47-53. PubMed ID: 23205587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson's disease: A meta-analysis.
    Lu SS; Gong FF; Feng F; Hu CY; Qian ZZ; Wu YL; Yang HY; Sun YH
    Biochem Biophys Res Commun; 2014 Oct; 453(3):653-61. PubMed ID: 25305495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-10-1082A/G and -592C/A polymorphisms with risk of Parkinson's disease: a meta-analysis.
    Jin J; Wu P; Li W; Shi J; Chen J; Li R; Tan S
    Int J Neurosci; 2014 Nov; 124(11):852-8. PubMed ID: 24397502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional parkin promoter polymorphism in Parkinson's disease: new data and meta-analysis.
    Chang XL; Mao XY; Li HH; Zhang JH; Li NN; Burgunder JM; Peng R; Tan EK
    J Neurol Sci; 2011 Mar; 302(1-2):68-71. PubMed ID: 21176923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP13A2 variants in early-onset Parkinson's disease patients and controls.
    Djarmati A; Hagenah J; Reetz K; Winkler S; Behrens MI; Pawlack H; Lohmann K; Ramirez A; Tadić V; Brüggemann N; Berg D; Siebner HR; Lang AE; Pramstaller PP; Binkofski F; Kostić VS; Volkmann J; Gasser T; Klein C
    Mov Disord; 2009 Oct; 24(14):2104-11. PubMed ID: 19705361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between mitochondrial DNA A10398G polymorphism and Parkinson's disease: a meta-analysis.
    Hua F; Zhang X; Hou B; Xue L; Xie A
    Oncotarget; 2017 Sep; 8(44):78023-78030. PubMed ID: 29100444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
    Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
    Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation analysis of the ATP13A2 gene in patients with PD and MSA from Italy.
    Gagliardi M; Procopio R; Nicoletti G; Morelli M; Brighina L; Quattrone A; Bonapace G; Malanga D; Quattrone A; Annesi G
    J Neurol Sci; 2021 Nov; 430():120031. PubMed ID: 34695705
    [No Abstract]   [Full Text] [Related]  

  • 37. The cis-Regulatory Element of SNCA Intron 4 Modulates Susceptibility to Parkinson's Disease in Han Chinese.
    Zhu SG; Lu H; Mao M; Li ZF; Cui L; Ovlyakulov B; Zhang X; Zhu JH
    Front Genet; 2020; 11():590365. PubMed ID: 33193729
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis.
    Ma CL; Su L; Xie JJ; Long JX; Wu P; Gu L
    J Neural Transm (Vienna); 2014 Feb; 121(2):123-34. PubMed ID: 24057652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of
    Li H; Zhang C; Ji Y
    Front Genet; 2021; 12():777942. PubMed ID: 34868266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Qiu X; Xiao Y; Wu J; Gan L; Huang Y; Wang J
    Front Neurol; 2019; 10():384. PubMed ID: 31057478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.